Ezetimibe-associated Rhabdomyolysis: A Comprehensive Assessment of the USFDA Adverse Event Reporting System Using Disproportionality Analysis, Case Reviews and Meta-analysis of Randomized Clinical Trials

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 90067663e99bce48-LAX IP: 101.37.83.79 UTC time: 2025-01-11T17:00:20+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4